bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.09.12.557499

Heteroscedastic Personalized Regression Unveils Genetic Basis of Alzheimer's Disease Stratified by Cognitive Level

Abstract

In contemporary medical research, patient heterogeneity plays a pivotal role in comprehending intricate diseases such as Alzheimers disease and various forms of cancer. Specifically, in the genomic analysis of Alzheimers disease, individual patients may exhibit unique causal mutations that significantly influence their therapeutic trajectory. Conventional models that share numerous parameters across all individuals struggle to discern this heterogeneity and identify the influential factors for individuals. To tackle this challenge, we propose an innovative approach called Heteroscedastic Personalized Regression (Het-PR) to estimate the heterogeneity across samples and obtain personalized models for each sample. We demonstrate the effectiveness and robustness of Het-PR through both simulation and real data experiments. In the simulation experiment, we show that Het-PR outperforms other state-of-the-art models in capturing inter-sample heterogeneity. In the real data experiment, we apply Het-PR to Alzheimers data and show that it can identify persuasive selected genetic factors for each individual patient. Interestingly, our results suggest that there might be different associative SNPs for AD patients stratified by different cognitive levels. Author summaryIn medical research, it has been observed that causes of a disease vary significantly among individuals, especially when looking at complex diseases like Alzheimers disease and cancer. For Alzheimers disease, obesity, age, gender, and depression may play different roles across different patients. When studying the genes of Alzheimers patients, we find that each person might have their own unique genetic changes that can affect their treatment. For example, Alzheimers patients with different genetic mutations may respond differently to the same treatment. Traditional research methods often miss these individual differences and cant always pinpoint important personalized factors for each patient, because they usually use one model for all patients. To better understand these differences, weve introduced a new method, Heteroscedastic Personalized Regression (Het-PR), which generates a personalized model for each individual. Our experiments show that Het-PR is more effective than other leading methods in identifying these patient differences and recognizing Alzheimers genetic basis for each patient through both simulation and real data experiments. When we used Het-PR on real Alzheimers data, it helped us spot key genetic factors for each patient. Additionally, in our study, we excitedly find that different genetic markers in Alzheimers patients are possibly based on their cognitive abilities. Software for Heteroscedastic Personalized Regression is available in https://github.com/rong-hash/Het-PR.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chen, Z., Wang, H.. 2023-09-15. Heteroscedastic Personalized Regression Unveils Genetic Basis of Alzheimer's Disease Stratified by Cognitive Level. https://doi.org/10.1101/2023.09.12.557499

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗